| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |